EA202191684A1 - Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии - Google Patents

Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии

Info

Publication number
EA202191684A1
EA202191684A1 EA202191684A EA202191684A EA202191684A1 EA 202191684 A1 EA202191684 A1 EA 202191684A1 EA 202191684 A EA202191684 A EA 202191684A EA 202191684 A EA202191684 A EA 202191684A EA 202191684 A1 EA202191684 A1 EA 202191684A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
ursodeoxycholic acid
treatment
presbiopia
drug containing
Prior art date
Application number
EA202191684A
Other languages
English (en)
Inventor
Масатомо Като
Томоко Ода
Кадзутака Кидо
Original Assignee
Сантен Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сантен Фармасьютикал Ко., Лтд. filed Critical Сантен Фармасьютикал Ко., Лтд.
Publication of EA202191684A1 publication Critical patent/EA202191684A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Изобретение относится к средству для лечения или профилактики заболеваний глаз, таких как пресбиопия, содержащему, в качестве активного ингредиента, урсодезоксихолевую кислоту или амидный конъюгат урсодезоксихолевой кислоты, или их сложные эфиры, или их фармацевтически приемлемые соли.
EA202191684A 2018-12-18 2019-12-17 Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии EA202191684A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018236717 2018-12-18
PCT/JP2019/049352 WO2020129964A1 (ja) 2018-12-18 2019-12-17 ウルソデオキシコール酸を含有する老視の治療または予防剤

Publications (1)

Publication Number Publication Date
EA202191684A1 true EA202191684A1 (ru) 2021-09-01

Family

ID=71100366

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191684A EA202191684A1 (ru) 2018-12-18 2019-12-17 Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии

Country Status (14)

Country Link
US (3) US20220072012A1 (ru)
EP (1) EP3900728A4 (ru)
JP (2) JP6771698B1 (ru)
KR (1) KR20210105916A (ru)
CN (1) CN113164499A (ru)
AU (1) AU2019407391A1 (ru)
BR (1) BR112021011653A2 (ru)
CA (1) CA3123370A1 (ru)
EA (1) EA202191684A1 (ru)
IL (1) IL284004A (ru)
MX (1) MX2021007161A (ru)
SG (1) SG11202106216SA (ru)
TW (1) TW202038966A (ru)
WO (1) WO2020129964A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021011653A2 (pt) * 2018-12-18 2021-09-08 Santen Pharmaceutical Co., Ltd. Agente contendo ácido ursodesoxicólico para tratamento ou prevenção de presbiopia
WO2022173043A1 (ja) * 2021-02-15 2022-08-18 参天製薬株式会社 ウルソデオキシコール酸またはその塩を含有する水性医薬組成物
US20220349486A1 (en) * 2021-04-29 2022-11-03 Baker Hughes Oilfield Operations Llc Modulating pilot valve adapter
WO2024034592A1 (ja) * 2022-08-09 2024-02-15 参天製薬株式会社 Ｕｄｃａまたはその塩を含有する水性医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2442647T3 (pl) 2009-06-15 2016-09-30 Związki ditiolowe, pochodne i ich zastosowania
CN102178784B (zh) * 2011-04-20 2013-06-12 威海康博尔生物药业有限公司 一种用于缓解视疲劳的药物组合物
US9724357B2 (en) * 2011-08-15 2017-08-08 Massachusetts Eye & Ear Infirmary Methods for preserving photoreceptor cell viability following retinal detachment
CN104083381A (zh) * 2014-07-29 2014-10-08 上海中医药大学 熊去氧胆酸的医药用途
US20170239273A1 (en) * 2014-08-22 2017-08-24 Kang Zhang Compositions and methods to treat and/or prevent vision disorders of the lens of the eye
CN109481450B (zh) * 2015-09-02 2021-07-23 盛世泰科生物医药技术(苏州)有限公司 一种用于预防和治疗白内障的眼用制剂及其制备方法
KR102252450B1 (ko) * 2017-02-09 2021-05-14 주식회사 아미코젠파마 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물
WO2018147685A1 (ko) * 2017-02-09 2018-08-16 주식회사 유스바이오팜 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물
JP6637217B2 (ja) * 2017-03-06 2020-01-29 株式会社坪田ラボ 近視予防又は抑制剤、マウス近視誘導モデルの作製方法、及び、近視予防又は抑制医薬スクリーニング方法
BR112021011653A2 (pt) 2018-12-18 2021-09-08 Santen Pharmaceutical Co., Ltd. Agente contendo ácido ursodesoxicólico para tratamento ou prevenção de presbiopia

Also Published As

Publication number Publication date
EP3900728A1 (en) 2021-10-27
KR20210105916A (ko) 2021-08-27
US20230040386A1 (en) 2023-02-09
CA3123370A1 (en) 2020-06-25
AU2019407391A1 (en) 2021-07-01
US11419880B2 (en) 2022-08-23
US20220096497A1 (en) 2022-03-31
WO2020129964A1 (ja) 2020-06-25
EP3900728A4 (en) 2022-08-17
US20220072012A1 (en) 2022-03-10
JP2021006548A (ja) 2021-01-21
CN113164499A (zh) 2021-07-23
BR112021011653A2 (pt) 2021-09-08
IL284004A (en) 2021-08-31
MX2021007161A (es) 2021-10-13
JP6771698B1 (ja) 2020-10-21
JPWO2020129964A1 (ja) 2021-02-15
TW202038966A (zh) 2020-11-01
SG11202106216SA (en) 2021-07-29

Similar Documents

Publication Publication Date Title
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
EA202090019A1 (ru) Спироциклические индолины в качестве модуляторов il-17
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
PH12016501355A1 (en) Bicyclic heterocyclic derivatives as bromodomain inhibitors
MX2020001403A (es) Nuevos derivados de quinolina.
EA202090573A1 (ru) Составы нирапариба
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
MX2020009235A (es) Formulacion oftalmica.
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
EA202190510A1 (ru) Новое лекарственное средство для лечения воспалительной болезни кишечника
EA202191548A1 (ru) Ингибиторы плазменного калликреина человека
MX2016012784A (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
MX2019003365A (es) Composiciones de ester de colina de acido lipoico y metodos para estabilizar en productos farmacologicos farmaceuticamente relevantes.
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
EA201691796A1 (ru) П-замещенные асимметричные мочевины и их применение в медицине
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
EA202190316A1 (ru) Конденсированное производное лактама
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
BR112017007095A2 (pt) conjugados e derivados de prostaglandina para tratamento de glaucoma e hipertensão ocular
EA201991817A1 (ru) Интраназальная композиция, включающая бетагистин
EA201992407A1 (ru) Конденсированные пентациклические производные имидазола в качестве модуляторов активности tnf
EA201590847A1 (ru) Новые ингибиторы rock
EA201800565A1 (ru) Композиция для лечения заболеваний уха, содержащая (+)-азасетрон
MX2023006235A (es) Composiciones para administracion de farmacos y metodos de uso de las mismas.